BIOMAT Database Logo BIOMAT Database Logo

Plasma heparin levels after administration of calcium and sodium salts of heparin. 1976

D P Thomas, and S Sagar, and J D Stamatakis, and F H Maffei, and A Erdi, and V V Kakkar

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001702 Biopharmaceutics The study of the physical and chemical properties of a drug and its dosage form as related to the onset, duration, and intensity of its action. Pharmaceutics,Pharmaceutic
D012964 Sodium A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. Sodium Ion Level,Sodium-23,Ion Level, Sodium,Level, Sodium Ion,Sodium 23
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

D P Thomas, and S Sagar, and J D Stamatakis, and F H Maffei, and A Erdi, and V V Kakkar
Comparative plasma heparin levels after subcutaneous sodium and calcium heparin.
October 1978, Thrombosis and haemostasis,
D P Thomas, and S Sagar, and J D Stamatakis, and F H Maffei, and A Erdi, and V V Kakkar
Comparative plasma heparin levels after subcutaneous administration of calcium and magnesium heparin.
January 1981, Thrombosis research,
D P Thomas, and S Sagar, and J D Stamatakis, and F H Maffei, and A Erdi, and V V Kakkar
Plasma heparin values and hemostasis in equids after subcutaneous administration of low-dose calcium heparin.
January 1988, American journal of veterinary research,
D P Thomas, and S Sagar, and J D Stamatakis, and F H Maffei, and A Erdi, and V V Kakkar
[Characterisation and evaluation of histamine in heparin, sodium and calcium salts (author's transl)].
January 1979, Annales pharmaceutiques francaises,
D P Thomas, and S Sagar, and J D Stamatakis, and F H Maffei, and A Erdi, and V V Kakkar
Measurement of plasma ionised calcium: comparison of calcium-titrated sodium heparin and lithium heparin as anticoagulants.
April 1987, Medical laboratory sciences,
D P Thomas, and S Sagar, and J D Stamatakis, and F H Maffei, and A Erdi, and V V Kakkar
GLC determination of plasma drug levels after oral administration of clorazepate potassium salts.
October 1975, Journal of pharmaceutical sciences,
D P Thomas, and S Sagar, and J D Stamatakis, and F H Maffei, and A Erdi, and V V Kakkar
Eosinophilic panniculitis after subcutaneous administration of sodium heparin.
January 2013, Indian journal of dermatology, venereology and leprology,
D P Thomas, and S Sagar, and J D Stamatakis, and F H Maffei, and A Erdi, and V V Kakkar
Blood plasma levels and elimination of salts of 2-PAM in man after oral administration.
July 1968, Journal of pharmaceutical sciences,
D P Thomas, and S Sagar, and J D Stamatakis, and F H Maffei, and A Erdi, and V V Kakkar
[Plasma monoglyceride hydrolases before and after heparin administration].
January 1977, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
D P Thomas, and S Sagar, and J D Stamatakis, and F H Maffei, and A Erdi, and V V Kakkar
[Influence of isoptin on the anticoagulant effect of the sodium and calcium salts of heparin].
January 1988, Farmakologiia i toksikologiia,
Copied contents to your clipboard!